Lenzing's €301 Million Is in the Bank, but the Fibre Maker's Real Bet Is on Fewer People and More Nonwovens
Published on 10/21/2026 at 22:21 | Editorial boerse-global.de
Lenzing has closed the books on its capital increase, pulling in roughly EUR 301.2 million gross from the sale of 34,756,362 new shares at EUR 8.65 apiece. Existing holders claimed 34,411,626 of them — 99% of the offering — with the syndicate banks placing the remainder on the market. The near-total take-up is a clear show of backing from the ownership base, though it should not be mistaken for proof that the turnaround will work. The subscription secures the funding, not the return.
What the money is actually for is a two-sided industrial reset. Lenzing intends to expand its nonwovens business while narrowing textiles to premium segments — the strategy it labels "Grow Nonwovens, Reset Textiles" — and to shore up its capital structure along the way. That combination of expansion in one unit and retrenchment in another is the heart of the plan, and it comes with a bill: impairments of up to EUR 150 million and provisions of around EUR 40 million are on the table.
A quarter of the workforce, gone within 18 months
Media reports indicate the company also plans to cut its headcount by a quarter, to below 6,000 employees, within the next 18 months. Read alongside the write-downs, the shape of the programme becomes clear: Lenzing is not simply raising more money to run the old business. It is reworking its industrial footprint, trading a broader textile approach for a premium-focused one while pouring resources into nonwovens.
Should investors sell immediately? Or is it worth buying Lenzing?
The rights issue itself was struck at a 10:9 ratio. Anyone who sat it out faces a relative stake diluted by roughly 47% — which makes this far more than a story about a stronger balance sheet. It is a concrete owner-level decision: put up fresh capital or hold a smaller slice of the company. The cash for the overhaul does not come free; it is matched by additional claims on future results.
Targets are targets, not results
Management is aiming, over the medium term, for an EBITDA improvement of EUR 150 million and an EBITDA margin of 20–25%, with net debt falling below 2.5 times EBITDA. Those are goals, not achievements — they tie the operational reorganisation to financial stabilisation, and the capital raise supplies the means while the earnings improvement has yet to materialise. Beyond equity, Lenzing has lined up new financing of up to EUR 300 million and an extension of existing liabilities through 2030.
Delivery and the start of trading of the new shares on the Vienna Stock Exchange are expected on 23 October 2026, subject to registration of the capital increase in the commercial register. That date is the anticipated next step, not a completed listing — the outcome of the offering is fixed, while settlement remains explicitly conditional. Investors' nearest concrete checkpoint is therefore that registration.
A 2.3% gain with no proven cause
The stock is up 2.3% today, though no confirmed causal link to the completion of the raise can be drawn from that move; attributing it to the announcement would go beyond what the company has confirmed. Reuters reported that news of the capital increase in early October had weighed on the shares. Today's advance and that earlier pressure are best kept apart. What matters substantively is how the proceeds are used and the still-conditional settlement — and, above all, whether a leaner industrial setup and extra capital actually translate into greater earning power. A successful placement is a prerequisite for that, not the result.
Ad
Lenzing Stock: New Analysis - 21 October
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
